Philip Morris Reports Today. The ZYN Story Just Changed.
FDA cleared modified-risk claims. The smoke-free transformation is accelerating.
FDA cleared modified-risk claims. The smoke-free transformation is accelerating.
China’s Kimi K3 lit the fuse. Hyperscaler earnings next week decide if the damage is temporary or structural.
An 86% EPS beat today just made insurance the most interesting trade in the market.
A parasite scare is dominating the headlines. The actual investment debate is about what this company looks like without Pizza Hut.
Q2 earnings on July 22 could be the next big catalyst.
A January 2027 ban on Chinese rare earth magnets just became the most overlooked supply shock in defense history.
McDonald’s is invading Starbucks’ turf. One stock is priced for it. The other is not.
A Q2 delivery beat and Fitch upgrade have the stock moving. Free cash flow is the real test.
The turnaround is real but slow. China is the problem nobody has solved yet.
XLV is leading, but not every part of healthcare is going the same direction.